Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | PRKDC | P78527 | 4/20 | 0.39 |
| ▸ | AHR | P35869 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | PIM1 | P11309 | 2/20 | 0.34 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.34 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.34 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.34 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21239197 | 0.91 | ALDH1A1 (0.41) | ALOX5PRKDCAHRALDH1A1HSD17B10 | |
| SCHEMBL25132104 | 0.91 | ALOX5 (0.44) | ALOX5PRKDCAHRALDH1A1HSD17B10 | |
| SCHEMBL25585495 | 0.90 | ALOX5 (0.51) | ALOX5PRKDCAHRALDH1A1KDM4E | |
| SCHEMBL25586496 | 0.89 | ALOX5 (0.48) | ALOX5PRKDCAHRALDH1A1KDM4E | |
| SCHEMBL21763744 | 0.88 | ALOX5 (0.48) | ALOX5PRKDCAHRALDH1A1HSD17B10 | |
| SCHEMBL26435834 | 0.88 | PIM1 (0.42) | ALOX5PRKDCAHRALDH1A1KDM4E | |
| SCHEMBL25585966 | 0.87 | ALOX5 (0.51) | ALOX5PRKDCAHRALDH1A1KDM4E | |
| SCHEMBL21239386 | 0.87 | AHR (0.45) | ALOX5PRKDCAHRALDH1A1HSD17B10 | |
| SCHEMBL23913445 | 0.86 | ALOX5 (0.49) | ALOX5PRKDCAHRALDH1A1KDM4E | |
| SCHEMBL25586094 | 0.86 | ALOX5 (0.46) | ALOX5PRKDCAHRALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | ALOX5 624/4885PRKDC 2965/4885AHR 2957/4885 |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | ALOX5 794/4885PRKDC 3279/4885AHR 3902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.